However, it was unclear whether the reduction in CD8+CD122+ T cells might result in increased susceptibility to chemotherapy or whether tumor shrinkage by chemotherapy might influence the fate of CD8+CD122+ T cells. This evidence concerns the gene CD8A and neoplasm.